Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hidden damage revealed.

J S Delmotte1

  • 1Endoscopy Department, Hospital and Medical University, Lille, France.

Scandinavian Journal of Rheumatology. Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal lesions require prompt endoscopic evaluation. Advanced electronic endoscopy aids in detecting these polymorphic lesions, including microlesions, and lower bowel damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

The American journal of gastroenterology·2017
Same author

Gastric mucosal surface in cirrhosis evaluated by magnifying endoscopy and scanning electronic microscopy.

Endoscopy·2000
Same author

Intraoperative endoscopy.

Gastrointestinal endoscopy clinics of North America·1998
Same author

Enteroscopy in small intestinal inflammatory diseases.

Gastrointestinal endoscopy clinics of North America·1998
Same author

[What is the usefulness of enteroscopy?].

Gastroenterologie clinique et biologique·1996
Same author

Perioperative endoscopy of the whole small bowel in Crohn's disease.

Gut·1993
Same journal

Abstract of the 35th Scandinavian Congress of Rheumatology, September 20-23, 2014, Stockholm, Sweden.

Scandinavian journal of rheumatology. Supplement·2014
Same journal

Abstracts of the 34th Scandinavian Congress of Rheumatology. Copenhagen, Denmark. September 2-5, 2012.

Scandinavian journal of rheumatology. Supplement·2012
Same journal

How should impaired morning function in rheumatoid arthritis be treated?

Scandinavian journal of rheumatology. Supplement·2011
Same journal

Morning stiffness and other patient-reported outcomes of rheumatoid arthritis in clinical practice.

Scandinavian journal of rheumatology. Supplement·2011
Same journal

How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.

Scandinavian journal of rheumatology. Supplement·2011
Same journal

How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?

Scandinavian journal of rheumatology. Supplement·2011
See all related articles

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
  • NSAID therapy can lead to gastrointestinal (GI) complications, including lesions.
  • These lesions may present asymptomatically or with severe symptoms like pain or hemorrhage.

Purpose of the Study:

  • To describe the endoscopic characteristics of NSAID-induced GI lesions.
  • To differentiate NSAID-induced lesions from spontaneous GI pathology.
  • To highlight the significance of lower bowel involvement in NSAID users.

Main Methods:

  • Review of endoscopic findings in patients undergoing NSAID therapy.
  • Classification of NSAID-induced GI lesions based on endoscopic appearance.

Related Experiment Videos

  • Comparison with spontaneous GI lesions and inflammatory bowel disease.

    • Main Results:

    • NSAID-induced GI lesions are polymorphic and lack clear parallels with spontaneous lesions.
    • Three main endoscopic types are identified: advanced focal/diffuse, large/hemorrhagic, and microlesions.
    • Lower bowel (ileocolonic) damage is common, resembling superficial inflammatory bowel disease.

    Conclusions:

    • NSAID-induced GI lesions necessitate suspicion in patients on NSAID therapy with GI symptoms or hemorrhage.
    • Advances in electronic endoscopy improve detection of microlesions.
    • Endoscopic findings in the lower bowel suggest NSAID-induced superficial inflammatory bowel disease.